HUTCHMED (China) Ltd（HCM）价格预测HCMHUTCHMED (China) Ltd

Alphio's HCM stock price prediction model matches the current HUTCHMED (China) Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.15 (+2.53%). The 1-week path is $14.39 (+4.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

HUTCHMED (China) Ltd is a good buy right now due to its current price of $14.36, which is below the analyst price targets of $16 to $18.50, indicating potential upside. The forward P/E ratio of 18.08 suggests that the stock is reasonably valued compared to future earnings expectations, while the recent positive news regarding licensing agreements with GSK is expected to generate significant revenue streams. However, the high P/E ratio of 1269.60 poses a risk, indicating that the stock may be overvalued if future growth does not meet expectations.

HUTCHMED (China) Ltd (HCM) last closed at $13.8000002, losing -3.29%. These facts feed the 1-day and 1-week HCM price prediction above.